August 26, 2012 at 18:01 PM EDT
(PSTI) Pluristem Therapeutics to Begin IC Phase II Trial
Pluristem Therapeutics, Inc. (PSTI) recently announced that it will be initiating phase II studies... Visit StockBlogHub to view complete post.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here